ArticleBritish journal of cancer2014

Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules.

J Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.